BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21924391)

  • 1. Major adverse upper gastrointestinal events in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention and dual antiplatelet therapy.
    Chen YL; Chang CL; Chen HC; Sun CK; Yeh KH; Tsai TH; Chen CJ; Chen SM; Yang CH; Hang CL; Wu CJ; Yip HK
    Am J Cardiol; 2011 Dec; 108(12):1704-9. PubMed ID: 21924391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
    Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Kaya MG; Uyarel H; Akpek M; Kalay N; Ergelen M; Ayhan E; Isik T; Cicek G; Elcik D; Sahin O; Cosgun SM; Oguzhan A; Eren M; Gibson CM
    Am J Cardiol; 2012 Feb; 109(4):486-91. PubMed ID: 22100027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
    Mangiacapra F; Muller O; Ntalianis A; Trana C; Heyndrickx GR; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Am J Cardiol; 2010 Nov; 106(9):1208-11. PubMed ID: 21029814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
    Uyarel H; Cam N; Okmen E; Kasikcioglu H; Tartan Z; Akgul O; Simsek D; Cetin M; Bozbeyoglu E; Buturak A; Uzunlar B
    Am Heart J; 2006 Jun; 151(6):1239.e1-7. PubMed ID: 16781226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.
    Patti G; Bárczi G; Orlic D; Mangiacapra F; Colonna G; Pasceri V; Barbato E; Merkely B; Edes I; Ostojic M; Wijns W; Di Sciascio G
    J Am Coll Cardiol; 2011 Oct; 58(15):1592-9. PubMed ID: 21958886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal bleeding and outcomes after percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chua SK; Liao CS; Hung HF; Cheng JJ; Chiu CZ; Chang CM; Lee SH; Lin SC; Liou JY; Lo HM; Kuan P; Shyu KG
    Am J Crit Care; 2011 May; 20(3):218-25. PubMed ID: 21532042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
    Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
    Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
    Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
    Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
    J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Suh JW; Mehran R; Claessen BE; Xu K; Baber U; Dangas G; Parise H; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
    J Am Coll Cardiol; 2011 Oct; 58(17):1750-6. PubMed ID: 21996385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction.
    Hermanides RS; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    EuroIntervention; 2010 May; 6(1):106-11. PubMed ID: 20542805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of five-year outcomes of patients with and without chronic total occlusion of noninfarct coronary artery after primary coronary intervention for ST-segment elevation acute myocardial infarction.
    Tajstra M; Gasior M; Gierlotka M; Pres D; Hawranek M; Trzeciak P; Lekston A; Polonski L; Zembala M
    Am J Cardiol; 2012 Jan; 109(2):208-13. PubMed ID: 21996144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.
    Feldman DN; Fakorede F; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2010 Feb; 105(3):323-32. PubMed ID: 20102943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.